Sun Pharma to purchase Concert Pharmaceuticals for $576M

Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million.

The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that has focused on developing the use of deuterium in medicinal chemistry and providing treatments for alopecia areata, an autoimmune disease that results in hair loss.